|
|
||||||||
|
FIGURE 2. Blood clearances of 99mTc-sulesomab (A) and 99mTc-HSA (B) in each individual subject. Symbol shapes (filled and open symbols) here and in Figure 4 correspond to 1 individual patient.
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |